Literature DB >> 27647055

CHARTing the Future Course of Tobacco-Cessation Interventions for Hospitalized Smokers.

Nancy A Rigotti1, Catherine M Stoney2.   

Abstract

Entities:  

Mesh:

Year:  2016        PMID: 27647055     DOI: 10.1016/j.amepre.2016.07.012

Source DB:  PubMed          Journal:  Am J Prev Med        ISSN: 0749-3797            Impact factor:   5.043


× No keyword cloud information.
  4 in total

1.  Interactive Voice Response Calls to Promote Smoking Cessation after Hospital Discharge: Pooled Analysis of Two Randomized Clinical Trials.

Authors:  Nancy A Rigotti; Yuchiao Chang; Lisa C Rosenfeld; Sandra J Japuntich; Elyse R Park; Hilary A Tindle; Douglas E Levy; Zachary Z Reid; Joanna Streck; Timothy Gomperts; Jennifer H K Kelley; Daniel E Singer
Journal:  J Gen Intern Med       Date:  2017-06-14       Impact factor: 5.128

2.  Evaluation of a Systems-Based Tobacco Cessation Program Using Bedside Volunteers.

Authors:  Denise S Taylor; Dominique Medaglio; Claudine T Jurkovitz; Freda Patterson; Zugui Zhang; Adebayo Gbadebo; Elisabeth Bradley; Rose Wessells; Edward Goldenberg
Journal:  Nicotine Tob Res       Date:  2020-03-16       Impact factor: 4.244

3.  Development of a Pharmacist-Led Opt-Out Cessation Treatment Protocol for Combustible Tobacco Smoking Within Inpatient Settings.

Authors:  Philip J Trapskin; Ann Sheehy; Paul D Creswell; Danielle E McCarthy; Amy Skora; Rob T Adsit; Anne E Rose; Candace Bishop; Jessica Bugg; Emily Iglar; Mark E Zehner; Daniel Shirley; Brian S Williams; Adam J Hood; Krista McElray; Timothy B Baker; Michael C Fiore
Journal:  Hosp Pharm       Date:  2021-03-05

4.  Can inpatient pharmacists move the needle on smoking cessation? Evaluating reach and representativeness of a pharmacist-led opt-out smoking cessation intervention protocol for hospital settings.

Authors:  Paul D Creswell; Danielle E McCarthy; Philip Trapskin; Ann Sheehy; Amy Skora; Robert T Adsit; Mark E Zehner; Timothy B Baker; Michael C Fiore
Journal:  Am J Health Syst Pharm       Date:  2022-06-07       Impact factor: 2.980

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.